The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial.

Jacob John, Sidhartha Giri, Arun S Karthikeyan, Dipti Lata, Shalini Jeyapaul, Anand K Rajan, Nirmal Kumar, Pavithra Dhanapal, Jayalakshmi Venkatesan, Mohanraj Mani, Janardhanan Hanusha, Uma Raman, Prabhakar D Moses, Asha Abraham, Sunil Bahl, Ananda S Bandyopadhyay, Mohammad Ahmad, Nicholas C Grassly, Gagandeep Kang
Author Information
  1. Jacob John: Department of Community Health, Christian Medical College, Vellore, Tamil Nadu, India.
  2. Sidhartha Giri: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  3. Arun S Karthikeyan: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  4. Dipti Lata: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  5. Shalini Jeyapaul: Department of Community Health, Christian Medical College, Vellore, Tamil Nadu, India.
  6. Anand K Rajan: Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India.
  7. Nirmal Kumar: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  8. Pavithra Dhanapal: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  9. Jayalakshmi Venkatesan: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  10. Mohanraj Mani: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  11. Janardhanan Hanusha: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  12. Uma Raman: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  13. Prabhakar D Moses: Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India.
  14. Asha Abraham: Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India.
  15. Sunil Bahl: WHO Regional Office for South-East Asia, New Delhi, India.
  16. Ananda S Bandyopadhyay: Bill & Melinda Gates Foundation, Seattle, Washington, USA.
  17. Mohammad Ahmad: WHO Country Office, New Delhi, India.
  18. Nicholas C Grassly: Department of Infectious Disease Epidemiology, Imperial College London, UK.
  19. Gagandeep Kang: Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.

Abstract

Background: In 2014, 2 studies showed that inactivated poliovirus vaccine (IPV) boosts intestinal immunity in children previously immunized with oral poliovirus vaccine (OPV). As a result, IPV was introduced in mass campaigns to help achieve polio eradication.
Methods: We conducted an open-label, randomized, controlled trial to assess the duration of the boost in intestinal immunity following a dose of IPV given to OPV-immunized children. Nine hundred healthy children in Vellore, India, aged 1-4 years were randomized (1:1:1) to receive IPV at 5 months (arm A), at enrollment (arm B), or no vaccine (arm C). The primary outcome was poliovirus shedding in stool 7 days after bivalent OPV challenge at 11 months.
Results: For children in arms A, B, and C, 284 (94.7%), 297 (99.0%), and 296 (98.7%), respectively, were eligible for primary per-protocol analysis. Poliovirus shedding 7 days after challenge was less prevalent in arms A and B compared with C (24.6%, 25.6%, and 36.4%, respectively; risk ratio 0.68 [95% confidence interval: 0.53-0.87] for A versus C, and 0.70 [0.55-0.90] for B versus C).
Conclusions: Protection against poliovirus remained elevated 6 and 11 months after an IPV boost, although at a lower level than reported at 1 month.
Clinical Trials Registration: CTRI/2014/09/004979.

Keywords

References

  1. Clin Infect Dis. 2012 Jun;54(11):1615-7 [PMID: 22437237]
  2. Science. 2014 Aug 22;345(6199):922-5 [PMID: 25146288]
  3. Lancet. 2014 Oct 25;384(9953):1505-12 [PMID: 25018120]
  4. J Infect Dis. 1991 Jan;163(1):1-6 [PMID: 1845806]
  5. J Immunol. 1999 Apr 15;162(8):5011-8 [PMID: 10202050]
  6. Vaccine. 2008 Feb 20;26(8):1083-90 [PMID: 18241962]
  7. J Infect Dis. 2014 Nov 1;210 Suppl 1:S439-46 [PMID: 24634499]
  8. N Engl J Med. 2010 Jun 24;362(25):2360-9 [PMID: 20573924]
  9. PLoS Pathog. 2012;8(4):e1002599 [PMID: 22532797]
  10. Emerg Infect Dis. 2017 Feb;23 (2):258-263 [PMID: 27861118]
  11. J Clin Microbiol. 2009 Jun;47(6):1939-41 [PMID: 19386844]
  12. Science. 2002 Apr 12;296(5566):356-9 [PMID: 11896235]
  13. Euro Surveill. 2013 Sep 19;18(38):null [PMID: 24084337]
  14. Lancet Infect Dis. 2015 Nov;15(11):1273-82 [PMID: 26318714]
  15. Lancet. 2016 Jul 9;388(10040):158-69 [PMID: 27212429]
  16. J Gen Virol. 2004 Jun;85(Pt 6):1571-9 [PMID: 15166441]
  17. J Infect Dis. 2012 May 15;205(10):1554-61 [PMID: 22448007]
  18. Wkly Epidemiol Rec. 2013 Jan 4;88(1):1-16 [PMID: 23311010]

Grants

  1. 001/World Health Organization
  2. D43 TW007392/FIC NIH HHS

MeSH Term

Antibodies, Neutralizing
Antibodies, Viral
Child, Preschool
Dose-Response Relationship, Immunologic
Feces
Female
Humans
Immunity, Mucosal
Immunization Schedule
Immunization, Secondary
India
Infant
Intestines
Male
Poliomyelitis
Poliovirus
Poliovirus Vaccine, Inactivated
Poliovirus Vaccine, Oral
Treatment Outcome
Vaccination
Virus Shedding

Chemicals

Antibodies, Neutralizing
Antibodies, Viral
Poliovirus Vaccine, Inactivated
Poliovirus Vaccine, Oral

Word Cloud

Created with Highcharts 10.0.0poliovirusvaccineIPVCchildrenBimmunitymonthsarmchallenge0inactivatedintestinaloralOPVrandomizedboostprimaryshedding7days11arms7%respectivelyPoliovirus6%versusBackground:20142studiesshowedboostspreviouslyimmunizedresultintroducedmasscampaignshelpachievepolioeradicationMethods:conductedopen-labelcontrolledtrialassessdurationfollowingdosegivenOPV-immunizedNinehundredhealthyVelloreIndiaaged1-4years1:1:1receive5enrollmentoutcomestoolbivalentResults:28494297990%29698eligibleper-protocolanalysislessprevalentcompared2425364%riskratio68[95%confidenceinterval:53-087]70[055-090]Conclusions:Protectionremainedelevated6althoughlowerlevelreported1monthClinicalTrialsRegistration:CTRI/2014/09/004979DurationIntestinalImmunityInactivatedVaccineBoosterDoseChildrenImmunizedOralVaccine:RandomizedControlledTrialhumanmucosal

Similar Articles

Cited By